期刊文献+

盐酸罗哌卡因及盐酸布比卡因用于高位硬膜外阻滞的临床比较 被引量:3

The Clinical Comparison of Ropivacaine Hydrochloride and Bupivacaine Hydrochloride Used in the Elevation Epidural Anesthesia
在线阅读 下载PDF
导出
摘要 目的:比较盐酸罗哌卡因与盐酸布比卡因高位硬膜外麻醉的临床效果和安全性。方法:选择ASAⅠ~Ⅱ级择期乳腺癌手术病人40例,随机分为2组,行T2—3间隙穿刺置管,I组注入0.375%盐酸罗哌卡因,Ⅱ组注入0.375%盐酸布比卡因,观察阻滞效果及HR、MAP、肺功能。结果:两组麻醉效果无差异,Ⅱ组对HR、MAP、肺功能抑制较强。结论:用0.375%盐酸罗哌卡因与0.375%盐酸布比卡因高位硬膜外麻醉,两者均具有相似的临床效果,0.375%盐酸罗哌卡因比0.375%盐酸布比卡因安全。 Objective: To compare the clinical effectiveness and safeness of ropivacaine hydrochloride and bupivacaine hydrochloride for the elevation epidural anesthesia. Method: Through selected 40 breast carcinoma patients of ASA Ⅰ~Ⅱ grade who need choose time operation, randomly divided for 2 groups, punctured the tube between the T2 - 3 interspace. The group I injected with 0. 375% ropivacaine hydrochlo- fide, and the group 11 injeeted with 0. 375% bupivacaine hydroehloride, to observe the blocking effective- ness,HR ,MAP and pulmonary function. Result: The blocking effectiveness between two groups have no difference, but the HR.MAP and pulmonary function inhibition stronger in the group 11. Conclusion: Both of them have similar clinical effectiveness for the elevation epidural anesthesia, used with 0.375% ropivacaine hydrochloride and 0. 375% bupivacaine hydrochloride, but the first one is safer.
出处 《河北医学》 CAS 2009年第1期7-9,共3页 Hebei Medicine
关键词 盐酸罗哌卡因 盐酸布比卡因 硬膜外阻滞 循环功能 肺功能 Ropivacaine hydrochloride Bupivacaine hydrochloride Epidural anesthesia Circulation function Pulmonary" function
  • 相关文献

参考文献3

二级参考文献19

  • 1Huang YF, Pryor ME, Mather LE et al. Cardiovascular and central nervous system effects of intravenous levobupivacaine and bupivacaine in sheep. Anesth Analg, 1998,86: 797-804.
  • 2Bardsley H, Gristwood R, Baker H, et al. A comparison of the cardiovascular effects of levobupivacaine and rac-bupivacaine following intravenous administration to healthy volunteers. Br J Clin Pharmacol, 1998,46: 245-249.
  • 3Lyons G, Columb M, Wilson RC,et al. Epidural pain relief in la bour: potencies of levobupivacaine and racemic bupivacaine. Br J Anaesth, 1998,81 : 899-901.
  • 4Zackova M, Manfredini P, Strali W, et al. Comparison of 0. 125 % bupivacaine and 0.2 % ropivacaine in obstetric analgesia. Minerva Anestesiol, 2000,66: 643-648.
  • 5Polley LS, Columb MO, Naughton NN,et al. Relative analgesic potencies of ropivacaine and bupivacaine for epidural analgesia in labor: implications for therapetic indexes. Anesthesiology,1999,90: 944-950.
  • 6McClellan KJ, Faulds D. Ropivacaine: an update of its use in regional anaesthesia. Drugs, 2000,60:1065-1093.
  • 7Robinson AP, Lyons GR, Wilson RC,et al. Levobupivacaine for epidural analgesia in labour; the sparings effect of epidural fentanyl. Anesth Analg, 2001,92:410-414.
  • 8Baeler MA, Tsen LC, Camann WR, et al. Clinical effects and maternal and fetal plasma of 0. 5 % epidural levobupivacaine versus bupivacaine for cesarean delivery. Anesthesiology, 1999,90:596-601.
  • 9Lee A,Fagan D,Lamont M,Tucker GT,Halldin M,Scott DB.Disposition kinetics of ropivacaine in humans[].Anesthesia and Analgesia.1989
  • 10Ekstrom G,Gunnarsson UB.Ropivacaine, a new amide-type local anesthetic agent, is metabolized by cytochromes P-450 1A and 3A in human liver microsomes[].Drug Metabolism and Disposition.1996

共引文献88

同被引文献38

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部